Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
International Journal of Hematology|July 19, 2014
Acute respiratory distress syndrome in a patient with primary myelofibrosis after ruxolitinib treatment discontinuationYan Beauverd, Kaveh SamiiRevue Medicale Suisse|June 13, 2025
[Hematologic malignancies and bone marrow anomalies in magnetic resonance imaging]Anne Guyard, Thomas Longval, Yan Beauverd, et al.Expert Opinion on Pharmacotherapy|September 22, 2015
Pacritinib: a new agent for the management of myelofibrosis?Yan Beauverd, Donal P McLornan, Claire N HarrisonEuropean Journal of Haematology|April 24, 2020
COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiencyYan Beauverd, Yannick Adam, Benjamin Assouline, et al.Neurology(R) Neuroimmunology & Neuroinflammation|July 4, 2015
Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal studyClaire Bridel, Yan Beauverd, Kaveh Samii, et al.Revue Medicale Suisse|November 12, 2011
[Monitoring of heparins and of anticoagulants]Yan Beauverd, Françoise Boehlen, Pierre Fontana, et al.Future Oncology (London, England)|February 6, 2016
Ruxolitinib: evolution or revolution in treatment of patients with polycythemia vera?Yan Beauverd, Donal P McLornan, Deepti H Radia, et al.Revue Medicale Suisse|January 29, 2026
[Management of thrombotic microangiopathy]Mathilde Fargeat, Maria Mappoura, Yan Beauverd, et al.Acta Haematologica|March 11, 2020
A Unique Case of Acquired Hemophilia A Presenting with Transient Ischemic AttackYan Beauverd, Françoise Boehlen, Loraine Fisch, et al.British Journal of Haematology|June 14, 2016
Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosisYan Beauverd, Samah Alimam, Donal P McLornan, et al.Pageof 3